Aclaris Therapeutics Inc Revenue per Employee (ACRS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Aclaris Therapeutics Inc   (NASDAQ: ACRS)
 

Aclaris Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Aclaris Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 87,685, above the company average.
Within the Healthcare sector Employees of 459 other companies have achieved higher revenue per employee. While Aclaris Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2253 to 3324. Aclaris Therapeutics Inc has 73 employees.


What is Sales per Employee Ratio?







ACRS Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change -55.11 % -8.33 % 37.18 % -85.94 % -24.09 %
Sales per Employee (TTM) $ 87,685 112,589 114,616 107,205 215,630
ACRS's Total Ranking # 3324 # 2253 # 2395 # 2639 #
Seq. Revenue Change -9.09 % -18.39 % 54.13 % -60.75 % 85.65 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 167
Healthcare Sector # 460
Overall Market # 3324

Revenue per Employee Statistics
High Average Low
$ 438,575 $ 208,115 $ 75,767
(Jun 30 2024)   (Jun 30 2020)



Financial Statements
Aclaris Therapeutics Inc 's Revenue MRQ $ 1 Millions Visit ACRS's Income Statement
Aclaris Therapeutics Inc 's Revenues TTM $ 6 Millions Visit ACRS's aggregate revenue growth
What are ACRS's Sales? Visit ACRS's Sales by Segment




Other Ratios
Aclaris Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ACRS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ACRS's Competitors
Revenue per Employee for ACRS's Suppliers
Revenue per Employee for ACRS's Customers

You may also want to know
ACRS's Sales Growth Rates ACRS's Pe Price to earnings ratio ACRS's Receivables Turnover Ratio ACRS's Stock Quote
ACRS's Net Income Growth Rates ACRS's Ps Price to Sales ratio ACRS's Sales per Employee ACRS's Asset Turnover Ratio
ACRS's Net Margin ACRS's Pb Price to Book ratio ACRS's Financial Strength Ratios ACRS's Dividend Payout Ratio
Date modified: 2026-11-09T18:44:15+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Lifestance Health Group Inc   152,986.86 $ 1,676.889  Million 10,961 
Encompass Health Corporation  150,907.14 $ 6,338.100  Million 42,000 
Profound Medical Corp   145,845.68 $ 23.627  Million 162 
Intellia Therapeutics Inc   140,283.82 $ 52.887  Million 377 
Crispr Therapeutics Ag  125,233.83 $ 25.172  Million 201 
Sonida Senior Living Inc   124,149.81 $ 638.130  Million 5,140 
Ensign Group Inc  123,354.46 $ 5,674.305  Million 46,000 
Abcellera Biologics Inc   120,743.77 $ 67.858  Million 562 
Pacs Group Inc   120,220.19 $ 5,705.049  Million 47,455 
U S Physical Therapy Inc  114,838.09 $ 837.629  Million 7,294 
Recursion Pharmaceuticals Inc   113,720.00 $ 68.232  Million 600 
Amarin Corp Plcuk  107,035.76 $ 176.609  Million 1,650 
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.